Clinical Trial Update: Erythrocyte Complement Receptor 1 and Alzheimer Disease [NA]

View source ↗

Summary

A completed clinical trial assessing erythrocyte complement receptor 1 in Alzheimer's disease. The study (NCT01565434) sponsored by CHU de Reims has finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: CHU de Reims | Conditions: Alzheimer Disease | NA | Status: COMPLETED